A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DDP

Search Conditions:
Search Keyword : DDP
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: DDP
Appearance Frequency: 450 time(s)
Long forms: 166

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
cis-diamminedichloroplatinum(II)
(153 times)
Neoplasms
(72 times)
DDTC (8 times)
BGD (6 times)
ADM (5 times)
1978 Platinum complexes in cancer chemotherapy.
cis-dichlorodiammineplatinum(II)
(63 times)
Neoplasms
(38 times)
ADR (2 times)
CR (2 times)
ERK (2 times)
1975 Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.
dynamic deconstructive psychotherapy
(9 times)
Therapeutics
(5 times)
BPD (7 times)
DBT (3 times)
DFST (2 times)
2008 A controlled trial of psychodynamic psychotherapy for co-occurring borderline personality disorder and alcohol use disorder.
detrimental drinking pattern
(7 times)
Substance-Related Disorders
(7 times)
CI (3 times)
EDs (3 times)
ED (2 times)
2012 Multi-level analysis of alcohol-related injury and drinking pattern: emergency department data from 19 countries.
dipole density plot
(6 times)
Biomedical Engineering
(2 times)
MEG (2 times)
CLSF (1 time)
MRI (1 time)
1990 State of the multichannel magnetoencephalography.
Dorsal defect of the patella
(6 times)
Radiology
(3 times)
MP (1 time)
1979 Dorsal defect of the patella (DDP): a characteristic radiographic lesion.
DDP cells to cisplatin
(5 times)
Neoplasms
(2 times)
5-FU (1 time)
AA (1 time)
ADR (1 time)
2005 [Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin].
deafness/dystonia peptide
(5 times)
Neurology
(2 times)
DDS (1 time)
1999 The human family of Deafness/Dystonia peptide (DDP) related mitochondrial import proteins.
density-dependent prophylaxis
(5 times)
Biology
(3 times)
PO (1 time)
2009 Rapid induction of immune density-dependent prophylaxis in adult social insects.
10  desirable dietary pattern
(5 times)
Public Health
(3 times)
--- 2000 [Assessment of dietary pattern in China with desirable dietary pattern].
11  dodecylphosphate
(4 times)
Biochemistry
(4 times)
DOPC (1 time)
DTP (1 time)
GMA (1 time)
1988 Effect of poly(ethylene glycol) on the Ca2+-induced fusion of didodecyl phosphate vesicles.
12  dual dynamic programming
(4 times)
Medical Informatics
(3 times)
DLD (1 time)
DP (1 time)
PL-DDP (1 time)
2000 Multiple protein sequence alignment using double-dynamic programming.
13  Dyadic Developmental Psychotherapy
(4 times)
Psychiatry
(4 times)
CAMHS (1 time)
RCT (1 time)
SDQ (1 time)
2014 Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United Kingdom.
14  differentiation-of-deception paradigm
(3 times)
Brain
(1 time)
ERPs (1 time)
1994 Electrodermal differentiation of deception: the effect of choice versus no choice of deceptive items.
15  double dose plateletpheresis
(3 times)
Hematology
(2 times)
CE (1 time)
PNC (1 time)
PT (1 time)
2007 Double dose plateletpheresis by continuous and intermittent flow devices increases platelet-neutrophil complex formation in healthy donors without noticeable neutrophil activation.
16  2,2-dihydroxy-diphenylpropane
(2 times)
Genetics
(2 times)
PTBP (2 times)
TTBP (2 times)
1975 [An experimental study of the morphogenetic properties of several phenols inducing phenocopies of vitiligo].
17  2,6-dimethyldifuro-8-pyrone
(2 times)
Rheumatology
(2 times)
AC (2 times)
SF (1 time)
2002 A cartilage derived novel compound DDP (2,6-dimethyldifuro-8-pyrone): isolation, purification, and identification.
18  cis-dichlorodiammine Pt(II)
(2 times)
Neoplasms
(2 times)
ActD (1 time)
BSO (1 time)
DMF (1 time)
1982 Protection against cis-dichlorodiammine Pt (II) cytotoxicity in vitro by cysteamine.
19  data-driven prognosis
(2 times)
ACL (1 time)
ACLR (1 time)
OA (1 time)
2015 Data-driven prognosis: a multi-physics approach verified via balloon burst experiment.
20  DDP-resistant
(2 times)
Medicine
(1 time)
miRNA (1 time)
MTT (1 time)
qRT-PCR (1 time)
2002 [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
21  deafness-dystonia protein gene
(2 times)
Cell Biology
(1 time)
BTK (1 time)
EST (1 time)
PTPC (1 time)
2000 Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition.
22  degree of differential prioritization
(2 times)
Medical Informatics
(1 time)
--- 2006 Differential prioritization between relevance and redundancy in correlation-based feature selection techniques for multiclass gene expression data.
23  depsipeptide
(2 times)
Chemistry Techniques, Analytical
(1 time)
AU-PAGE (1 time)
HDACs (1 time)
MALDI-TOF MS (1 time)
2005 Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors.
24  dexamethasone dipropionate
(2 times)
Chemistry
(1 time)
--- 2012 Release profiles of dexamethasone dipropionate from admixtures of steroid and heparinoid ointments prepared by different mixing methods.
25  dextrodropropizine
(2 times)
Chemistry Techniques, Analytical
(1 time)
LDP (2 times)
TD (1 time)
2019 Enantioselective LC-ESI-MS/MS determination of dropropizine enantiomers in rat plasma and application to a pharmacokinetic study.
26  di-n-dodecyl hydrogen phosphate
(2 times)
Chemistry
(2 times)
BAM (2 times)
L-Arg (1 time)
LC (1 time)
2006 Interactions of L-arginine with Langmuir monolayers of di-n-dodecyl hydrogen phosphate at the air-water interface.
27  diamindichloridoplatin
(2 times)
Dentistry
(1 time)
5-FU (1 time)
PP2A (1 time)
PP2Ac (1 time)
2013 Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
28  different schedules of cisplatin
(2 times)
Neoplasms
(1 time)
PTEN (1 time)
1992 Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity.
29  disturbance decoupling problem
(2 times)
Cybernetics
(1 time)
BCNs (1 time)
SBCNs (1 time)
STP (1 time)
2016 Disturbance Decoupling of Singular Boolean Control Networks.
30  docetaxel, 5-fluorouracil and cisplatin
(2 times)
Medicine
(2 times)
5-FU (1 time)
AGC (1 time)
MST (1 time)
2014 Joint detection of ERCC1, TUBB3, and TYMS guidance selection of docetaxel, 5-fluorouracil and cisplatin (DDP) individual chemotherapy in advanced gastric cancer patients.
31  dose-limiting side-effects of cisplatin
(2 times)
Neoplasms
(1 time)
AAs (1 time)
Cys (1 time)
DCT (1 time)
2000 Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines.
32  double-digest problem
(2 times)
Medical Informatics
(2 times)
GA (1 time)
1994 Equivalence classes for the double-digest problem with coincident cut sites.
33  (E)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one
(1 time)
Biochemistry
(1 time)
--- 2014 (E)-3-(3,4-dihydroxy-2-methoxyphenyl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one, a novel licochalcone B derivative compound, suppresses lipopolysaccharide-stimulated inflammatory reactions in RAW264.7 cells and endotoxin shock in mice.
34  2,4-di-tert-butylphenyl diphenyl phosphate
(1 time)
Chemistry
(1 time)
2-tBuDP (1 time)
TPP (1 time)
2013 Dynamics and mechanism of flame retardants in polymer matrixes: experiment and simulation.
35  3,4-dihydroxybenzaldehyde-2,4-dinitrophenylhydrazone
(1 time)
Biotechnology
(1 time)
AC (1 time)
CNTs (1 time)
CPE (1 time)
2011 A highly sensitive nanostructure-based electrochemical sensor for electrocatalytic determination of norepinephrine in the presence of acetaminophen and tryptophan.
36  4,4'-dithiodipyridine
(1 time)
Chemistry
(1 time)
DTNB (1 time)
DTT (1 time)
2002 Involvement of amino-acid side chains of membrane proteins in the binding of glutathione to pig cerebral cortical membranes.
37  4-Dicyanomethylene 2,6-Dimethyl-4H-Pyran
(1 time)
Spectrometry, Fluorescence
(1 time)
ACM (1 time)
DMAC (1 time)
DMF (1 time)
2018 Photophysical and Electrochemical Studies of 4-Dicyanomethylene 2,6-Dimethyl-4H-Pyran (DDP) Dye with Amides in Water.
38  6-diamino-2,4-dihydroxypyrimidine sulfate
(1 time)
Biochemistry
(1 time)
GO (1 time)
MGO (1 time)
2019 Determination of glyoxal and methylglyoxal in serum by UHPLC coupled with fluorescence detection.
39  9,10-dihydro-10-(2,3-di(hydroxycarbonyl) propyl)-10-phosphaphenanthrene-10-oxide
(1 time)
Biophysics
(1 time)
AFM (1 time)
DSC (1 time)
POM (1 time)
2011 Morphology and interference color in spherulite of poly(trimethylene terephthalate) copolyester with bulky linking pendent group.
40  co-delivery of two drugs, cisplatin
(1 time)
Drug Therapy
(1 time)
FA (1 time)
FA-PEG-DSPE (1 time)
NLCs (1 time)
2016 Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer.
41  Data Driven Parcellization
(1 time)
Medicine
(1 time)
EEG (1 time)
HB (1 time)
MEG (1 time)
2013 MEG source localization of spatially extended generators of epileptic activity: comparing entropic and hierarchical bayesian approaches.
42  Day 1-5 or 120-hour infusion every 21 days, or cisplatin
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
CBR (1 time)
GEM (1 time)
2007 [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
43  day and weekly low-dose cisplatin
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
1990 5-Fluorouracil infusion and low-dose weekly cisplatin: an analysis of increased toxicity.
44  day dosing of cisplatin
(1 time)
Neoplasms
(1 time)
MS (1 time)
TGD (1 time)
TNF-alpha (1 time)
1996 Tumor necrosis factor-alpha (TNF alpha) enhances cisplatin cytotoxicity to ovarian carcinoma xenografts.
45  day plus cis-diamminedichloroplatinum
(1 time)
Neoplasms
(1 time)
MeCCNU (1 time)
MTX (1 time)
1980 Chemotherapy of advanced, hormonally resistant prostatic carcinoma.
46  Days of drain permanence
(1 time)
General Surgery
(1 time)
--- 2018 Low Versus High Vacuum Suction Drainage of the Submuscular Pocket in Primary Breast Reconstruction: A Retrospective Study.
47  days to death of the plant
(1 time)
Communicable Diseases
(1 time)
DWIL (1 time)
DWWP (1 time)
2015 Modified inoculation and disease assessment methods reveal host specificity in Erwinia tracheiphila-Cucurbitaceae interactions.
48  DDP cells and inhibited cisplatin
(1 time)
Molecular Biology
(1 time)
3'-UTR (1 time)
EMT (1 time)
GC (1 time)
2019 MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
49  DDP cells were treated with cisplatin
(1 time)
Natural Science Disciplines
(1 time)
OSCC (1 time)
2014 WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
50  DDP Lachema CSSR
(1 time)
Gynecology
(1 time)
--- 1989 [The effectiveness of platinum in mono- anc combination therapy in a prospective multicenter study].
51  DDP to cisplatin
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
DC13 (1 time)
FACS (1 time)
2003 [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
52  decrease cell proliferation and reverse cisplatin
(1 time)
Biology
(1 time)
AML (1 time)
miRNAs (1 time)
2018 MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
53  decylammonium dihydrogen phosphate
(1 time)
Chemistry
(1 time)
CMP (1 time)
ODP (1 time)
1998 Crystal Structures of a Series of Novel Alkylammonium Phosphates and Their Formation in Aluminophosphate Synthesis Mixtures.
54  deep dragging process
(1 time)
Environmental Health
(1 time)
--- 2016 Effects of dredging at Aratu port in All Saints Bay, Brazil: monitoring the metal content in water and sediments.
55  defective deep placentation
(1 time)
Reproductive Medicine
(1 time)
GD (1 time)
Pg (1 time)
2018 Porphyromonas gingivalis strain-dependent inhibition of uterine spiral artery remodeling in the pregnant rat.
56  delay discounting paradigm
(1 time)
Psychiatry
(1 time)
CGT (1 time)
2014 Dysfunctional decision-making in pathological gambling: pattern specificity and the role of impulsivity.
57  Delay Discounting Procedure
(1 time)
Substance-Related Disorders
(1 time)
GT (1 time)
RDMT (1 time)
2001 Three decision-making tasks in cocaine-dependent patients: do they measure the same construct?
58  delayed nephrotoxicity after cisplatin
(1 time)
Neoplasms
(1 time)
--- 1986 Cumulative or delayed nephrotoxicity after cisplatin (DDP) treatment.
59  delivered by pDC316-hIL-24 transfection and cisplatin
(1 time)
Neoplasms
(1 time)
IHC (1 time)
IL (1 time)
PDGF (1 time)
2015 Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
60  delivering HSulf-1 combined with cisplatin
(1 time)
Neoplasms
(1 time)
HPEI (1 time)
RT-PCR (1 time)
2012 The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.
61  delta, and beta, on cisplatin
(1 time)
Neoplasms
(1 time)
AG (1 time)
1990 The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cells.
62  demand printing
(1 time)
Biomedical Engineering
(1 time)
HEPM (1 time)
PCL (1 time)
SEM (1 time)
2006 Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering.
63  Dementia and Disability Project in Thai Elderly
(1 time)
Neurology
(1 time)
MCI (1 time)
MRI (1 time)
2013 The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results.
64  demineralized dentin powder
(1 time)
Dentistry
(1 time)
PAA (1 time)
STMP (1 time)
2010 A chemical phosphorylation-inspired design for Type I collagen biomimetic remineralization.
65  Demographic Data Profile
(1 time)
Education
(1 time)
DSP (1 time)
UTCVM (1 time)
2005 Stress management interventions for veterinary students.
66  demonstrate the anti-drug resistance of YPFS in cisplatin
(1 time)
Natural Science Disciplines
(1 time)
YPFS (1 time)
2016 Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling.
67  demonstrated previously that cisplatin
(1 time)
Neoplasms
(1 time)
AEBSs (1 time)
TAM (1 time)
1997 Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.
68  demonstrated that 17-AAG alone or in combination with cisplatin
(1 time)
Medicine
(1 time)
AC (1 time)
CMap (1 time)
2011 Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma.
69  demonstrated that miR-199a affected ovarian cancer cell resistance to cisplatin
(1 time)
Neoplasms
(1 time)
HIF-1alpha (1 time)
2017 miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1alpha.
70  demonstrated that the chemotherapy drug Cisplatin
(1 time)
Molecular Biology
(1 time)
QYSL (1 time)
2018 Qiyusanlong decoction suppresses lung cancer in mice via Wnt/beta-catenin pathway.
71  demonstrated that the combination of OMT with cisplatin
(1 time)
Neoplasms
(1 time)
LLC (1 time)
NSCLC (1 time)
OMT (1 time)
2018 Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8+ T Cells in Non-small Cell Lung Cancer.
72  density of dental practitioners
(1 time)
Health Services Research
(1 time)
--- 2011 Density of dental practitioners and access to dental care for the elderly: a multilevel analysis with a view on socio-economic inequality.
73  density-dependent hypothesis
(1 time)
Environmental Health
(1 time)
--- 2010 Density-dependent prophylactic immunity reconsidered in the light of host group living and social behavior.
74  dependent Dirichlet process
(1 time)
Statistics as Topic
(1 time)
MM (1 time)
2013 Bayesian Non-Parametric Hierarchical Modeling for Multiple Membership Data in Grouped Attendance Interventions.
75  depression during pregnancy
(1 time)
Psychology
(1 time)
ADP (1 time)
DADP (1 time)
LBW (1 time)
2017 Symptoms of anxiety and depression during pregnancy and their association with low birth weight in Chinese women: a nested case control study.
76  Dera Din Panah
(1 time)
Tropical Medicine
(1 time)
--- 2009 Production performance of Dera Din Panah goat under desert range conditions in Pakistan.
77  derivatives and their referenced concentrations (X) were: Cisplatin
(1 time)
Neoplasms
(1 time)
CARBO (1 time)
TETRA (1 time)
1993 Comparison of cytotoxicity and cell kinetic perturbations of 5 platinum compounds in gynecologic cancer cell-lines.
78  derivatives cis-dichlorodiammine platinum(II)
(1 time)
Antineoplastic Agents
(1 time)
CBDCA (1 time)
CP (1 time)
1985 In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
79  derived from lung cancer cells confer cisplatin
(1 time)
Nanotechnology
(1 time)
miRNA (1 time)
mTOR (1 time)
2017 Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
80  DES and cisplatin
(1 time)
Pharmacognosy
(1 time)
DES (1 time)
FCM (1 time)
HCC (1 time)
2012 The suppression effects of desacetyluvaricin on hepatocellular carcinoma and its possible mechanism.
81  detect the sensitivity of transfected BEL7402/5-FU to cisplatin
(1 time)
Allergy and Immunology
(1 time)
ADM (1 time)
MMC (1 time)
MRE11 (1 time)
2013 [Effect of plasmid transfected shMRE11 on the drug-resistance of BEL7402/5-FU hepatoma cells].
82  detected cellular senescence after cisplatin
(1 time)
Medicine
(1 time)
DEX (1 time)
GCs (1 time)
TIS (1 time)
2012 Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer.
83  determinant of cancer cell sensitivity to alkylating agents and cisplatin
(1 time)
Neoplasms
(1 time)
NER (1 time)
1998 Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.
84  determine the characteristics of pharmacokinetics with high-dose cisplatin
(1 time)
Gynecology
(1 time)
AUC (1 time)
i.v (1 time)
1996 [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
85  determine the maximum dose-intensity of cisplatin
(1 time)
Neoplasms
(1 time)
IA (1 time)
1994 Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer.
86  determined by differential pulse polarography
(1 time)
Chemistry Techniques, Analytical
(1 time)
--- 2000 Differential pulse polarography determination of indium after column preconcentration with [1-(2-pyridylazo)-2-naphthol]-naphthalene adsorbent or its complex on microcrystalline naphthalene.
87  determined for cisplatin
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
HB-EGF (1 time)
IR (1 time)
2003 Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.
88  determined that miR-204-5p increases 5-fluorouracil and cisplatin
(1 time)
Neoplasms
(1 time)
--- 2017 miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma.
89  determining plasma and renal tissue concentrations of cisplatin
(1 time)
Medicine
(1 time)
DDTC (1 time)
HPLC (1 time)
2010 [High-performance liquid chromatography-based determination of plasma and renal tissue cisplatin levels after subcutaneous cisplatin implantation in mice].
90  determining the macromolecular binding and cytotoxicity of cisplatin
(1 time)
Molecular Biology
(1 time)
--- 1986 Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
91  development dysplasia of patella
(1 time)
Orthopedics
(1 time)
--- 2000 The unstable patella in children.
92  development of hypoxia-induced cisplatin
(1 time)
Medicine
(1 time)
HIF-1alpha (1 time)
KLF5 (1 time)
mTOR (1 time)
2018 Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1alpha-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
93  deviation of depth perception
(1 time)
Traumatology
(1 time)
ANOVA (1 time)
DVA (1 time)
HR (1 time)
2014 A study on the effects of fatigue driving and drunk driving on drivers' physical characteristics.
94  devised a new systemic chemotherapy using cisplatin
(1 time)
Antineoplastic Agents
(1 time)
STS (1 time)
1985 [Systemic chemotherapy with super-high dose cisplatin and sodium thiosulfate (STS) rescue in mice].
95  diabetes during pregnancy
(1 time)
Medicine
(1 time)
--- 2018 Offspring sex impacts DNA methylation and gene expression in placentae from women with diabetes during pregnancy.
96  diabetic distal polyneuropathy
(1 time)
Endocrinology
(1 time)
BDI (1 time)
QL (1 time)
VAS (1 time)
2009 [Depressive symptoms and quality of life in type 2 diabetic patients with diabetic distal polyneuropathy].
97  diagnosis disclosure procedure
(1 time)
Health Services
(1 time)
PCP (1 time)
2016 Primary care physicians and oncologists are partners in cancer announcement.
98  diagnostic decision point
(1 time)
Asthma
(1 time)
OFC (1 time)
PPV (1 time)
sIgE (1 time)
2016 Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy.
99  dialyzed polysaccharide
(1 time)
Molecular Biology
(1 time)
CE (1 time)
CP (1 time)
DP (1 time)
2009 Antioxidative activity of polysaccharide fractions isolated from Lycium barbarum Linnaeus.
100  diamino-dichloro-cis-platinum II
(1 time)
Allergy and Immunology
(1 time)
CMC (1 time)
MLTC (1 time)
1983 The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response.